Stay updated on Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Sign up to get notified when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.

Latest updates to the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page
- Check6 days agoChange DetectedA new publication citation has been added to the Publications section, referencing Keeley et al.'s work on asthma symptom diaries, which provides additional context for the patient-reported outcome measures used in the study.SummaryDifference0.0%

- Check13 days agoChange DetectedThere are no additions or deletions in the changes data. The page content remains unchanged relative to the source input.SummaryDifference0.0%

- Check21 days agoChange DetectedThe page now displays Revision: v3.5.4 instead of v3.5.3, indicating an update to the page's revision label rather than any changes to the study content.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating the page content has been updated to a newer revision.SummaryDifference0.0%

- Check49 days agoChange DetectedPage revision updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.0%

- Check56 days agoChange DetectedIQVIA Pty Ltd was added to the Collaborators list. The entry 'Iqvia Pty Ltd' was removed and reformatted with correct capitalization.SummaryDifference0.0%

Stay in the know with updates to Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Enter your email address, and we'll notify you when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.